Argenica Therapeutics LtdASX: AGN

Phase 2 Trial Promising Improvements in Functional Outcomes

Oct 15, 2025 at 1:48 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment